other material
confidence high
sentiment negative
materiality 0.85
Ocean Biomedical files audited FY2022 financials; auditor flags going concern with $34K cash vs $12.7M liabilities
Ocean Biomedical, Inc.
- Cash at Dec 31, 2022: $34K; total current liabilities $12.7M; working capital deficit of $10.8M.
- Auditor's report includes going-concern emphasis: substantial doubt about ability to continue.
- Net loss for FY2022 not disclosed in this excerpt, but accumulated deficit and negative equity implied.
- Deferred offering costs of $1.8M suggest ongoing capital-raising efforts.
- Short-term loans of $776K outstanding; accounts payable and accrued expenses $11.4M.